Showing results (2401-2410 of 2,424) with videos related to

Sort By:
Pageof 243
American Journal of Human Genetics|April 18, 2017
Germline Mutations in CDH23, Encoding Cadherin-Related 23, Are Associated with Both Familial and Sporadic Pituitary AdenomasQilin Zhang, Cheng Peng, Jianping Song, et al.
JAMA|August 14, 2020
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical TrialsShengli Xia, Kai Duan, Yuntao Zhang, et al.
Clinical Genitourinary Cancer|May 10, 2025
Clinical Outcomes and Safety Profile of Neoadjuvant PD-1 Inhibitors Combined With VEGFR-TKI Versus VEGFR-TKI in Nonmetastatic Renal Cell CarcinomaCheoklong Ng, Cheng Peng, Shangqian Wang, et al.
Virologica Sinica|April 9, 2021
Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human PrimatesYan-Feng Yao, Ze-Jun Wang, Ren-Di Jiang, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2021
Identification and Functional Characterization of Metabolites for Bone Mass in Peri- and Postmenopausal Chinese WomenRui Gong, Hong-Mei Xiao, Yin-Hua Zhang, et al.
Frontiers in Immunology|July 11, 2022
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 TrialShengli Xia, Kai Duan, Yuntao Zhang, et al.
Science (New York, N.Y.)|September 1, 2022
Single-cell Stereo-seq reveals induced progenitor cells involved in axolotl brain regenerationXiaoyu Wei, Sulei Fu, Hanbo Li, et al.
Nature Communications|November 9, 2023
NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexingWei Feng, Joanne C Beer, Qinyu Hao, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
NULISA: a novel proteomic liquid biopsy platform with attomolar sensitivity and high multiplexingWei Feng, Joanne Beer, Qinyu Hao, et al.
Eclinicalmedicine|July 12, 2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trialWanshen Guo, Kai Duan, Yuntao Zhang, et al.
Pageof 243